1. Patrick W. Serruys

    0 Comments Leave a Comment

    1-15 of 129 1 2 3 4 5 6 7 8 9 »
    1. Mentioned In 129 Articles

    2. Tissue coverage and neointimal hyperplasia in overlap versus nonoverlap segments of drug-eluting stents 9 to 13 months after implantation: In vivo assessment with optical coherence tomography

      Tissue coverage and neointimal hyperplasia in overlap versus nonoverlap segments of drug-eluting stents 9 to 13 months after implantation: In vivo assessment with optical coherence tomography

      Background: Histologic experimental studies have reported incomplete neointimal healing in overlapping with respect to nonoverlapping segments in drug-eluting stents (DESs), but these observations have not been confirmed in human coronary arteries hitherto. On the contrary, angiographic and optical coherence tomography studies suggest that DES overlap elicits rather an exaggerated than an incomplete neointimal reaction.Methods: Optical coherence tomography studies from 2 randomized trials including sirolimus-eluting, biolimus-eluting, everolimus-eluting, and zotarolimus-eluting stents were analyzed at 9- to 13-month follow-up. Coverage in overlapping segments was compared versus the corresponding nonoverlapping segments of the same stents, using statistical pooled analysis.Results: Forty-two overlaps were ...

      Read Full Article
    3. Edge Vascular Response After Percutaneous Coronary Intervention : An Intracoronary Ultrasound and Optical Coherence Tomography Appraisal: From Radioactive Platforms to First- and Second-Generation Drug-Eluting Stents and Bioresorbable Scaffolds

      Edge Vascular Response After Percutaneous Coronary Intervention : An Intracoronary Ultrasound and Optical Coherence Tomography Appraisal: From Radioactive Platforms to First- and Second-Generation Drug-Eluting Stents and Bioresorbable Scaffolds
      ...u Onuma, MD^⁎, * Takashi Muramatsu, MD, PhD^⁎, * Vasim Farooq, MBChB^⁎, * Christos V. Bourantas, MD, PhD^⁎, * Patrick W. Serruys, MD, PhD^⁎^, Corresponding author contact information ^, E-mail the corresponding author * ...
      Read Full Article
    4. One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent. An optical coherence tomography study

      One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent. An optical coherence tomography study
      ...lahanty MD^1, 8. Alejandro Santos MD^1, 9. Victoria Martin-Yuste MD, PhD^1, 10. Monica Masotti MD, PhD^1, 11. Patrick W. Serruys MD, PhD^2, 12. Stephan Windecker MD, PhD^3, 13....
      Read Full Article
    5. Randomized study to assess the effect of thrombus aspiration on flow area in patients with ST-elevation myocardial infarction: an optical frequency domain imaging study—TROFI trial

      Randomized study to assess the effect of thrombus aspiration on flow area in patients with ST-elevation myocardial infarction: an optical frequency domain imaging study—TROFI trial

      Aims Primary percutaneous coronary intervention (PPCI) with thrombectomy (TB) seems to reduce the thrombus burden, resulting in a larger flow area as measured with optical frequency domain imaging (OFDI). Methods and results In a multi-centre study, 141 patients with ST elevation myocardial infarction <12 h from onset were randomized to either PPCI with TB using an Eliminate catheter (TB: n = 71) or without TB (non-TB: n = 70), having operators blinded for the OFDI results. The primary endpoint was minimum flow area (MinFA) post-procedure assessed by OFDI, defined as: [stent area + incomplete stent apposition (ISA) area] − (intraluminal defect + tissue prolapse area ...

      Read Full Article
    6. Do we have a future with transcatheter adventitial delivery of stem cells?

      Do we have a future with transcatheter adventitial delivery of stem cells?

      Critically evaluating the methodology of the adventitial delivery of stem cells, some specific options should be underlined. Adventitia as the most superficial layer, consisting of connective tissue has to be distinguished of perivascular tissues. By strict definition, an adventitia is the outermost connective tissue covering any organ, or vessel. The “adventitial” delivery of stem cells with a 1 mm micro-needle means a delivery to superficial so called pericardial myocardium, perivascular fat tissues, including a risk of perforation and injury of soft tissues. In fact, the mapping of the artery with visualization of the three-layer vessel structure and perivascular tissues as ...

      Read Full Article
    7. Letter by Bourantas et al Regarding Article, "Nonculprit Plaques in Patients With Acute Coronary Syndromes Have More Vulnerable Features Compared With Those With Non-Acute Coronary Syndromes: A 3-Vessel Optical Coherence Tomography Study"

      Letter by Bourantas et al Regarding Article, "Nonculprit Plaques in Patients With Acute Coronary Syndromes Have More Vulnerable Features Compared With Those With Non-Acute Coronary Syndromes: A 3-Vessel Optical Coherence Tomography Study"
      ...cal Coherence Tomography Study” 1. Christos V. Bourantas, MD, PhD, 2. Hector M. Garcia-Garcia, MD, PhD and 3. Patrick W. Serruys, MD, PhD 1. Thorax Center, Erasmus Medical Center, Rotterdam, The Netherlands To the Editor...
      Read Full Article
    8. In vivo three dimensional optical coherence tomography. A novel imaging modality to visualize the edge vascular response - Corrected Proof

      In vivo three dimensional optical coherence tomography. A novel imaging modality to visualize the edge vascular response - Corrected Proof

      The edge vascular response (EVR) has been previously evaluated with sound-based imaging modalities utilizing tissue characterization properties namely intravascular ultrasound (IVUS) and virtual histology IVUS (VH-IVUS) after implantation of metallic devices or bioresorbable drug-eluting platforms . The majority of these reports have shown lumen loss (LL) at the proximal edge, although in some studies the vascular response at the edges was diverse with proximal and distal lumen gain.

      Read Full Article
    9. First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold: A Multi-Imaging Modality Study

      First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold: A Multi-Imaging Modality Study
      ...t Vascular, Santa Clara, CA (R.R.); and Cardialysis, Rotterdam, the Netherlands (H.G.G.) 1. Correspondence to Patrick W. Serruys, MD, PhD, Thoraxcenter, Ba-583‘s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands...
      Read Full Article
    10. Long-Term Vascular Healing in Response to Sirolimus- and Paclitaxel-Eluting StentsLong-Term Vascular Healing in Response to Sirolimus- and Paclitaxel-Eluting Stents: An Optical Coherence Tomography Study

      Long-Term Vascular Healing in Response to Sirolimus- and Paclitaxel-Eluting StentsLong-Term Vascular Healing in Response to Sirolimus- and Paclitaxel-Eluting Stents: An Optical Coherence Tomography Study

      Objectives This study sought to assess stent strut coverage, malapposition, protrusion, and coronary evaginations as markers of healing 5 years after implantation of sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES), by optical coherence tomography (OCT). Background Early-generation drug-eluting stents have been shown to delay vascular healing. Methods A total of 88 event-free patients with 1 randomly selected lesion were suitable for final OCT analysis 5 years after drug-eluting stent implantation. The analytical approach was based on a hierarchical Bayesian random-effects model. Results OCT analysis was performed at 5 years in 41 SES lesions with 6,380 struts, and in 47 ...

      Read Full Article
    11. Thrombotic arch in ST-segment elevation myocardial infarction: comparison between two-dimensional and three-dimensional optical frequency domain imaging

      Thrombotic arch in ST-segment elevation myocardial infarction: comparison between two-dimensional and three-dimensional optical frequency domain imaging
      ...rison between two-dimensional and three-dimensional optical frequency domain imaging 1. Takashi Muramatsu, 2. Patrick W. Serruys and 3. Yoshinobu Onuma* 1. Department of Interventional Cardiology, Thoraxcenter, Erasmus...
      Read Full Article
    12. Letter by Garcia-Garcia et al Regarding Article, "Impact of Frequency-Domain Optical Coherence Tomography Guidance for Optimal Coronary Stent Implantation in Comparison With Intravascular Ultrasound Guidance"

      Letter by Garcia-Garcia et al Regarding Article, "Impact of Frequency-Domain Optical Coherence Tomography Guidance for Optimal Coronary Stent Implantation in Comparison With Intravascular Ultrasound Guidance"
      ...on With Intravascular Ultrasound Guidance” 1. Hector M. Garcia-Garcia, MD, PhD, 2. Yoshinobu Onuma, MD and 3. Patrick W. Serruys, MD, PhD 1. Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands To the Editor:...
      Read Full Article
    13. Five-Year Optical Coherence Tomography Follow-Up of an Everolimus-Eluting Bioresorbable Vascular Scaffold: Changing the Paradigm of Coronary Stenting?

      Five-Year Optical Coherence Tomography Follow-Up of an Everolimus-Eluting Bioresorbable Vascular Scaffold: Changing the Paradigm of Coronary Stenting?
      ...cular Scaffold Changing the Paradigm of Coronary Stenting? 1. Antonios Karanasos, MD; 2. Cihan Simsek, MD; 3. Patrick Serruys, MD, PhD; 4. Jurgen Ligthart, BSc; 5. Karen Witberg, CCRN; 6. Robert-Jan van Geuns, MD, PhD; 7...
      Read Full Article
    14. High-speed intracoronary optical frequency domain imaging: implications for three-dimensional reconstruction and quantitative analysis

      High-speed intracoronary optical frequency domain imaging: implications for three-dimensional reconstruction and quantitative analysis

      AIM: To assess the reproducibility of quantitative analysis of optical frequency domain imaging (OFDI) acquired at different pullback speeds (20, 30, 40 mm/sec), as well as the impact of cardiac motion artefact on three-dimensional (3D) reconstructions. METHODS AND RESULTS: A total of 36 OFDI pullbacks were obtained pre- and post-stent implantation at the pullback speeds of 20, 30 and 40 mm/sec in non-diseased swine coronary arteries. The amount of x-ray contrast needed for blood clearance during OFDI imaging was recorded. Three-dimensional images of stented segments were rendered and artefacts on 3D images were assessed. Lumen areas (LA) were ...

      Read Full Article
    15. Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol VShield device for the treatment of intravascular ultrasound and optical coherence tomography-derived thin cap fibroatheromas (TCFAS) in native coronary arteries

      Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol VShield device for the treatment of intravascular ultrasound and optical coherence tomography-derived thin cap fibroatheromas (TCFAS) in native coronary arteries

      Aims: The aim of the pilot SECRITT trial was to evaluate the safety and feasibility of sealing the high risk IVUS and optical coherence tomography-derived thin cap fibroatheroma (TCFA), with a dedicated nitinol self-expanding vShield device. Methods and results: After screening with angiography, fractional flow reserve (FFR), intravascular ultrasound virtual histology (IVUS-VH) and optical coherence tomography (OCT), 23 patients met enrolment criteria (presence of non-obstructive VH-derived TCFA lesion with thin cap on OCT) and were randomised to vShield (n=13) versus medical therapy (n=10). In the shielded group, baseline percent diameter stenosis was 33.2±13.5%, FFR was ...

      Read Full Article
    16. 1-15 of 129 1 2 3 4 5 6 7 8 9 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Doppler, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Patrick W. Serruys

    Patrick W. Serruys

    Patrick W. Serruys is a Professor of Interventional Cardiology, Erasmus University, Thoraxcentrum Rotterdam, Netherlands. Prof. Dr. Patrick Serruys comes from Belgium and studied at the University of Leuven. In 1972 he obtained his doctor's degree at the University of Leuven. He worked at this university in the Cardiology department until 1976 and then joined the Thoraxcenter in Rotterdam. In 1986 he obtained his PhD on the thesis: "Transluminal coronary angioplasty: an investigational tool and a non operative treatment of acute myocardial ischemia". In 1988 he was appointed Professor of Interventional Cardiology at the Thoraxcenter of the Erasmus MC.

  3. Quotes

    1. The positive 30-day results reaffirm my belief that a device that bioresorbs, or disappears, into the body after restoring blood flow is the next logical step in the treatment of cardiovascular disease.
      In Abbott Announces Positive Data From Absorb Trial on Its Bioresorbable Vascular Scaffold Technology
    2. I am very happy with the 12-month results of the LEADERS study, which confirm the 9-month results. The Biosensors drug eluting stent, combining the novel biolimus drug and an abluminal biodegradable polymer, is a very promising technology for our patients long term benefit
      In iosensors DES Demonstrates Superior Strut Coverage to Industry Leading DES